Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years
Patients should maintain realistic expectations and continue treatment as prescribed, even if immediate improvements are not apparent, as premature discontinuation can lead to symptom recurrence
If you are still treating protein as a single ingredient rather than a spectrum of different consumer needs, you are missing the actual opportunity
The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Another major strength of this study is its novel exploration of under-researched conditions, including PTSD and OCD
There is also the slight risk of nerve injury with IM shots